ロード中...
Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer’s Disease Clinical Trial Recruitment
INTRODUCTION: The apolipoprotein E (APOE) gene is the strongest known genetic risk factor for sporadic Alzheimer’s disease (AD). APOE can be used as an enrichment strategy or inclusion criterion for AD prevention trials. Personal genomics companies market direct-to-consumer (DTC) genetic tests, incl...
保存先:
| 出版年: | Alzheimer Dis Assoc Disord |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8044253/ https://ncbi.nlm.nih.gov/pubmed/33060367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000421 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|